Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Biologics and Blistering - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Through Suction Blistering
Sponsor: Wei-Che Ko
This PHASE2/PHASE3 trial investigates Allergic Contact Dermatitis and Skin Inflammation and is currently actively recruiting participants. Wei-Che Ko leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Recruiting PHASE2/PHASE3
-
Nov 2025 — Dec 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2025 — Nov 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2024 — Jul 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
▶ Show 3 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2023 — Jun 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2022 — Jul 2023 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Wei-Che Ko
For direct contact, visit the study record on ClinicalTrials.gov .